Histopathological Changes in Lesional and Perilesional Vitiligo Skin

Background : Vitiligo is a skin disease with complex, multifactorial pathogenesis. Abnormalities in surrounding keratinocytes may cause melanocyte death due to deprivation of growth factors. Objective : To evaluate Haematoxylin and Eosin (H&E) histopathological findings in lesional and perilesional vitiliginous skin. Patients Methods : Lesional skin biopsies were taken from 18 vitiligo patients. Perilesional biopsies were taken from 5 patients. All biopsies were stained with Hematoxylin and Eosin for histopathological assessment. Results : Detected changes in lesional skin included increased epidermal thickness, epidermal atrophy, focal disruption of dermoepidermal junction and vacuolar degeneration with focal degree. All examined sections showed congested blood vessels and scanty melanin pigment. Dermal perivascular lymphocytic infiltration was present in all cases. Detected changes in perilesional skin included increased epidermal thickness, epidermal atrophy, plenty of melanin pigment and focal vacuolar alteration. All examined sections showed congested blood vessels and focally disrupted dermoepidermal junction. Dermal perivascular lymphocytic infiltration was present in all sections. Conclusion : Histopathological changes occur in perilesional as well as lesional vitiligo skin. Therefore, topical or physical treatment for vitiligo should be extended to the surrounding apparently normal skin. This may help in arresting disease course by preventing subclinical or silent lesions from progression to clinically visible lesions.

[1]  P. Rousselle,et al.  The Human Epidermal Basement Membrane: A Shaped and Cell Instructive Platform That Aging Slowly Alters , 2020, Biomolecules.

[2]  Vivek Gupta,et al.  Clinical and Histopathological Study in Vitiligo Patients , 2019, journal of Medical Science And clinical Research.

[3]  H. Gamil,et al.  Histopathological Findings in Lesional and Perilesional Skin of Vitiligo Patients Before and After Narrow Band Ultraviolet B Phototherapy , 2019, Zagazig University Medical Journal.

[4]  Vivek T. Natarajan,et al.  Mapping architectural and transcriptional alterations in non-lesional and lesional epidermis in vitiligo , 2017, Scientific Reports.

[5]  N. van Geel,et al.  Vitiligo: An Update on Pathophysiology and Treatment Options , 2017, American Journal of Clinical Dermatology.

[6]  G. Mohammed,et al.  Highlights in pathogenesis of vitiligo. , 2015, World journal of clinical cases.

[7]  E. S. Hewedy,et al.  Clinical and ultrastructural study of nevus depigmentosus , 2013 .

[8]  K. Schallreuter,et al.  A review of the worldwide prevalence of vitiligo in children/adolescents and adults , 2012, International journal of dermatology.

[9]  A. Abdou,et al.  Immunolocalization of Tenascin-C in Vitiligo , 2012, Applied immunohistochemistry & molecular morphology : AIMM.

[10]  M. Picardo,et al.  Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference , 2012, Pigment cell & melanoma research.

[11]  Aroni Kyriaki,et al.  Correlating epidermal thickness and basement membrane length to angiogenesis in the centre and the periphery of vitiligo lesion. , 2012, Indian journal of dermatology, venereology and leprology.

[12]  Meaghan Daly,et al.  Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. , 2011, Journal of the American Academy of Dermatology.

[13]  S. Glassman Vitiligo, reactive oxygen species and T-cells. , 2011, Clinical science.

[14]  R. Clark,et al.  First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi , 2010, Pigment cell & melanoma research.

[15]  E. Patsouris,et al.  Increased angiogenesis and mast cells in the centre compared to the periphery of vitiligo lesions , 2010, Archives of Dermatological Research.

[16]  Eun-So Lee,et al.  Histopathologic Features in Vitiligo , 2008, The American Journal of dermatopathology.

[17]  C. Assaf,et al.  Sequential immunohistochemical study of depigmenting and repigmenting minigrafts in vitiligo. , 2003, European journal of dermatology : EJD.

[18]  M. Abdel-Aty,et al.  Prevalence of skin diseases in rural areas of Assiut Governorate, Upper Egypt , 2003, International journal of dermatology.

[19]  D. Tobin,et al.  Melanocytes are not absent in lesional skin of long duration vitiligo. , 2000, The Journal of pathology.

[20]  D. Bartosik,et al.  Molecular and functional analysis of pTAV320, a repABC-type replicon of the Paracoccus versutus composite plasmid pTAV1. , 1998, Microbiology.

[21]  H. Wulf,et al.  Photoprotection in vitiligo and normal skin. A quantitative assessment of the role of stratum corneum, viable epidermis and pigmentation. , 1996, Acta dermato-venereologica.

[22]  W. Westerhof,et al.  Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. , 1993, The Journal of investigative dermatology.

[23]  J. Ortonne,et al.  Vitiligo: where do we stand? , 1993, Pigment cell research.

[24]  R. Misra,et al.  Neural differentiation of melanocytes in vitiliginous skin. , 1988, Acta Anatomica.